|
Alzheimer's Disease Clinical Trials in Fresno, CA
2 recruiting studies within 50 miles
Phase
| Trial | Phase | Dist. |
|---|---|---|
| Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type | Phase 3 | 1 mi |
| ACP-204 in Adults With Alzheimer's Disease Psychosis | Phase 2/3 | 1 mi |
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.